Cargando…

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients

Identifying modifiable risk factors of peritoneal dialysis (PD)-related peritonitis is of clinical importance in patient care. Mineral bone disease (MBD) has been associated with mortality and morbidity in end-stage kidney disease (ESKD) patients. However, its influence on PD related peritonitis due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Chia-Te, Zheng, Cai-Mei, Lin, Yen-Chung, Wu, Mei-Yi, Lin, Yuh-Feng, Hsu, Yung-Ho, Hsu, Chih-Cheng, Wu, Mai-Szu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806837/ https://www.ncbi.nlm.nih.gov/pubmed/33441921 http://dx.doi.org/10.1038/s41598-020-80938-2

Ejemplares similares

Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)

Roles of Serum Calcium, Phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis Patients: A Nationwide, Population-based Longitudinal Study Using TWRDS 2005–2012
por: Liu, Chung-Te, et al.
Publicado: (2017)

Baseline Peritoneal Membrane Transport Characteristics Are Associated with Peritonitis Risk in Incident Peritoneal Dialysis Patients
por: Chou, Yi-Hsin, et al.
Publicado: (2022)

Hungry bone syndrome in peritoneal dialysis patients after parathyroid surgery
por: Yeh, Heng, et al.
Publicado: (2023)

A feasibility study of avoiding positive calcium balance and parathyroid hormone increase in patients on peritoneal dialysis
por: Piraciaba, Maria Clara Teixeira, et al.
Publicado: (2022)

Prophylactic Antibiotics for Endoscopy-Associated Peritonitis in Peritoneal Dialysis Patients
por: Wu, Hsin-Hsu, et al.
Publicado: (2013)

Incidence and clinical features of patients with peritoneal dialysis peritonitis complicated by bacteremia
por: Tsai, Chang-Chih, et al.
Publicado: (2018)

Encapsulating Peritoneal Sclerosis in Long-Termed Peritoneal Dialysis Patients
por: Hsu, Heng-Jung, et al.
Publicado: (2018)

Peritoneal-Membrane Characteristics and Hypervolemia Management in Peritoneal Dialysis: A Randomized Control Trial
por: Li, Szu-Yuan, et al.
Publicado: (2021)

Citrobacter Peritoneal Dialysis Peritonitis: Rare Occurrence with Poor Outcomes
por: Chao, Chia-Ter, et al.
Publicado: (2013)

Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study
por: Yang, Yuqi, et al.
Publicado: (2021)

The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage
por: Lee, Yi-Che, et al.
Publicado: (2019)

Acinetobacter Peritoneal Dialysis Peritonitis: A Changing Landscape over Time
por: Chao, Chia-Ter, et al.
Publicado: (2014)

Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series
por: Chao, Chia-Ter, et al.
Publicado: (2013)

Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers
por: Davenport, Andrew
Publicado: (2023)

Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
por: You, Xiaohan, et al.
Publicado: (2020)

Oral Tori in Chronic Peritoneal Dialysis Patients
por: Hsu, Chia-Lin, et al.
Publicado: (2016)

Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients?
por: Chang, Yuanmay, et al.
Publicado: (2022)

Do Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Have the Same Clinical Outcomes? A Ten-year Cohort Study in Taiwan
por: Tang, Chao-Hsiun, et al.
Publicado: (2016)

Effects of Cholesterol Levels on Mortality in Patients with Long-Term Peritoneal Dialysis Based on Residual Renal Function
por: Lin, Yen-Chung, et al.
Publicado: (2018)

Total Bilirubin in Prognosis for Mortality in End‐Stage Renal Disease Patients on Peritoneal Dialysis Therapy
por: Yang, Tsung‐Lin, et al.
Publicado: (2017)

Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis
por: Murashima, Miho, et al.
Publicado: (2023)

Relationship between the Serum Parathyroid Hormone and Magnesium Levels in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients using Low-magnesium Peritoneal Dialysate
por: Cho, Min Seok, et al.
Publicado: (2002)

The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis
por: Lin, Lin, et al.
Publicado: (2019)

Transperitoneal Calcium Balance in Anuric Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients
por: Hamada, Chieko, et al.
Publicado: (2013)

The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis
por: Chang, Chia-Ning, et al.
Publicado: (2021)

Transitions of dialysis status and outcomes after the unplanned first dialysis: a nationwide population-based cohort study
por: Liao, Chia-Te, et al.
Publicado: (2023)

Survey of urinary nickel in peritoneal dialysis patients
por: Huang, Ya-Ching, et al.
Publicado: (2017)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Serum Phosphorus and Albumin in Patients Undergoing Peritoneal Dialysis: Interaction and Association With Mortality
por: Huang, Naya, et al.
Publicado: (2021)

Association between blood cadmium levels and malnutrition in peritoneal dialysis
por: Hsu, Ching-Wei, et al.
Publicado: (2014)

Case Report of a Patient Undergoing Peritoneal Dialysis with Encapsulating Peritoneal Sclerosis Superimposed With Calciphylaxis
por: Li Tsai, Jun, et al.
Publicado: (2016)

Pathophysiology of the Peritoneal Membrane during Peritoneal Dialysis: The Role of Hyaluronan
por: Yung, Susan, et al.
Publicado: (2011)

Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients
por: Jeong, Sohyun, et al.
Publicado: (2017)

Multidisciplinary predialysis education reduces incidence of peritonitis and subsequent death in peritoneal dialysis patients: 5-year cohort study
por: Hsu, Cheng-Kai, et al.
Publicado: (2018)

A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis
por: Chuang, Po-Hsun, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Li, Yi-Chen, et al.
Publicado: (2021)

Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis
por: Tseng, Min-Hua, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8mp7m43q2s7hqu7u9m9fanu0rq